Overview
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
Status:
Completed
Completed
Trial end date:
2009-10-13
2009-10-13
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety and efficacy of HMPL-004 in patients with active mild to moderate ulcerative colitis (UC), compared with placebo.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hutchison Medipharma Limited
Criteria
Inclusion Criteria:- Have active confirmed mild to moderate ulcerative colitis
Exclusion Criteria:
- Diagnosed with Crohn's Disease or